Investor Presentation

Intl. Biotechnology Trust PLC
29 October 2024
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Investor Presentation

 

International Biotechnology Trust plc is pleased to announce that Ailsa Craig and Marek Poszepczynski will provide a live presentation on the Company's results for the year ended 31 August 2024 via the Investor Meet Company platform on Tuesday 5 November 2024 at 14:00 pm GMT.

 

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:

https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor

 

Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the Investor Meet Company platform will automatically be invited.

 

ENDS

 

Enquiries:

 

Schroder Investment Management Limited

 

Charlotte Banks (Press)

Kirsty Preston

 

Kerry Higgins (Company Secretary)                   

 

 

020 7658 6000

 

 

020 7658 6000

 


 

Kaso Legg Communications (Financial PR)

 

Charles Gorman                       

Henry Taylor

Effie Aye Maung Hider

 

 

 

 

IBT@kl-communications.com


 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings